Virbac SA (EPA:VIRP)
France · Delayed Price · Currency is EUR 371.50
+8.50 (2.34%)
Apr 30, 2026, 5:35 PM CET
Virbac Market Cap
Virbac has a market cap or net worth of €3.11 billion as of May 1, 2026. Its market cap has increased by 24.88% in one year.
Market Cap
3.11B
Enterprise Value
3.28B
Revenue
1.46B
Ranking
n/a
PE Ratio
20.64
Stock Price
€371.50
Market Cap Chart
Since August 8, 1994, Virbac's market cap has increased from 217.52M to 3.11B, an increase of 1,330.84%. That is a compound annual growth rate of 8.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 3.11B | 3.92% |
| Dec 31, 2025 | 3.00B | 13.00% |
| Dec 31, 2024 | 2.65B | -12.68% |
| Dec 29, 2023 | 3.04B | 57.52% |
| Dec 30, 2022 | 1.93B | -46.24% |
| Dec 31, 2021 | 3.58B | 78.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sanofi | 96.39B |
| EssilorLuxottica Société anonyme | 83.65B |
| Sartorius Stedim Biotech | 15.25B |
| Ipsen | 13.71B |
| bioMérieux | 8.46B |
| ABIVAX Société Anonyme | 7.64B |
| emeis Société anonyme | 2.31B |
| Clariane SE | 1.44B |